Development and preliminary validation of the Adult Asthma Adherence Questionnaire™.
Development and preliminary validation of the Adult Asthma Adherence Questionnaire™.
复制标题
成人哮喘依从性问卷的开发和初步验证。
DOI:
10.1016/j.jaip.2013.03.001
复制
发表时间:
2013
期刊:
影响因子:
--
通讯作者:
Turner-Bowker,DianeM
中科院分区:
文献类型:
--
作者:
Schatz,Michael;Zeiger,RobertS;Yang,Su-Jau;Weinstein,AndrewG;Chen,Wansu;Saris-Baglama,ReneeN;Turner-Bowker,DianeM
BackgroundAsthma medication adherence is related to better asthma outcomes, but identification of suboptimal patient adherence behavior is not standardized in clinical settings.ObjectveThe purpose of this study was to develop a practical questionnaire that reflects nonadherence risk and identifies potential adherence barriers.MethodsA questionnaire that included 20 potential adherence questions was completed by 420 adult patients with asthma who filled a prescription for an inhaled corticosteroid (ICS) and a short-acting beta agonist (SABA) in the previous 6 months. Questions without substantial floor or ceiling effects that were significantly related to self-reported low adherence or previous ICS canister dispensings were identified. Internal consistency reliability was tested by Cronbach α. Relationships of these questions to Asthma Control Test scores, future percent of days covered for ICS dispensings, and future asthma exacerbations and SABA dispensings were determined.ResultsFive final questions were identified: following “my medication plan,” forgetting, not “needing” the medications, side effects, and cost. Low internal consistency reliability (<0.50) suggested items should not be summarized by a single score. All five questions were related to Asthma Control Test scores. Following the medication plan, forgetting, and not needing medication were significantly related to prospective percent of days covered. Side effects were related to subsequent SABA and oral corticosteroid dispensings, and cost was significantly related to oral corticosteroid dispensings.ConclusionsWe identified five questions related to other measures of adherence and to asthma control that can be used clinically to identify patients at risk of nonadherence and the specific adherence barriers involved.